Patient Understanding of the Importance of β-Blocker Use in the Perioperative Period

David M. Rosenfeld, Terrence L. Trentman, Joseph G. Hentz, Susan G. Hagstrom, John H. Demenkoff

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: Perioperative β-adrenergic blockade has been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to determine patient knowledge of the importance of perioperative β-blockade in a population already taking chronic therapy and to assess the effectiveness of medical and surgical providers in patient education regarding these benefits. Design: Survey. Setting: Teaching hospital. Participants: One hundred twenty-six patients taking daily β-blockers presenting to a preoperative medical evaluation clinic completed a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Intervention: None. Measurements and Main Results: Mean coronary artery disease risk factors per individual were 3.2 (standard deviation, 1.5). Forty-nine percent indicated that β-blockers are beneficial in the perioperative period. Of those identifying benefit, 8% recognized decrease in myocardial infarction or decrease in mortality as the reason. Sixty-nine percent of patients who identified perioperative benefit cited blood pressure control as the reason. This correlated to the 67% of the total sample who identified their indication for the medication as antihypertensive. Only 7% recalled their prescribing physician ever mentioning the β-blocker in relation to surgery. The same percentage recalled their surgeon mentioning it in relation to the planned procedure. Conclusions: This study suggests low patient understanding of the potential importance and reasons for perioperative β-blockade. Patients who recognized perioperative benefit identified antihypertensive versus cardioprotective effects. Clinicians can improve education of patients already taking daily β-blockers regarding these potential benefits.

Original languageEnglish (US)
Pages (from-to)325-329
Number of pages5
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume21
Issue number3
DOIs
StatePublished - Jun 2007

Fingerprint

Perioperative Period
Patient Education
Antihypertensive Agents
Mortality
Teaching Hospitals
Adrenergic Agents
Coronary Artery Disease
Myocardial Infarction
Blood Pressure
Morbidity
Physicians
Population

Keywords

  • β-blocker
  • myocardial infarction
  • patient education
  • perioperative

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Patient Understanding of the Importance of β-Blocker Use in the Perioperative Period. / Rosenfeld, David M.; Trentman, Terrence L.; Hentz, Joseph G.; Hagstrom, Susan G.; Demenkoff, John H.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 21, No. 3, 06.2007, p. 325-329.

Research output: Contribution to journalArticle

Rosenfeld, David M. ; Trentman, Terrence L. ; Hentz, Joseph G. ; Hagstrom, Susan G. ; Demenkoff, John H. / Patient Understanding of the Importance of β-Blocker Use in the Perioperative Period. In: Journal of Cardiothoracic and Vascular Anesthesia. 2007 ; Vol. 21, No. 3. pp. 325-329.
@article{e1dbe925b2354280a553173fad8770e9,
title = "Patient Understanding of the Importance of β-Blocker Use in the Perioperative Period",
abstract = "Objective: Perioperative β-adrenergic blockade has been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to determine patient knowledge of the importance of perioperative β-blockade in a population already taking chronic therapy and to assess the effectiveness of medical and surgical providers in patient education regarding these benefits. Design: Survey. Setting: Teaching hospital. Participants: One hundred twenty-six patients taking daily β-blockers presenting to a preoperative medical evaluation clinic completed a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Intervention: None. Measurements and Main Results: Mean coronary artery disease risk factors per individual were 3.2 (standard deviation, 1.5). Forty-nine percent indicated that β-blockers are beneficial in the perioperative period. Of those identifying benefit, 8{\%} recognized decrease in myocardial infarction or decrease in mortality as the reason. Sixty-nine percent of patients who identified perioperative benefit cited blood pressure control as the reason. This correlated to the 67{\%} of the total sample who identified their indication for the medication as antihypertensive. Only 7{\%} recalled their prescribing physician ever mentioning the β-blocker in relation to surgery. The same percentage recalled their surgeon mentioning it in relation to the planned procedure. Conclusions: This study suggests low patient understanding of the potential importance and reasons for perioperative β-blockade. Patients who recognized perioperative benefit identified antihypertensive versus cardioprotective effects. Clinicians can improve education of patients already taking daily β-blockers regarding these potential benefits.",
keywords = "β-blocker, myocardial infarction, patient education, perioperative",
author = "Rosenfeld, {David M.} and Trentman, {Terrence L.} and Hentz, {Joseph G.} and Hagstrom, {Susan G.} and Demenkoff, {John H.}",
year = "2007",
month = "6",
doi = "10.1053/j.jvca.2007.02.001",
language = "English (US)",
volume = "21",
pages = "325--329",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Patient Understanding of the Importance of β-Blocker Use in the Perioperative Period

AU - Rosenfeld, David M.

AU - Trentman, Terrence L.

AU - Hentz, Joseph G.

AU - Hagstrom, Susan G.

AU - Demenkoff, John H.

PY - 2007/6

Y1 - 2007/6

N2 - Objective: Perioperative β-adrenergic blockade has been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to determine patient knowledge of the importance of perioperative β-blockade in a population already taking chronic therapy and to assess the effectiveness of medical and surgical providers in patient education regarding these benefits. Design: Survey. Setting: Teaching hospital. Participants: One hundred twenty-six patients taking daily β-blockers presenting to a preoperative medical evaluation clinic completed a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Intervention: None. Measurements and Main Results: Mean coronary artery disease risk factors per individual were 3.2 (standard deviation, 1.5). Forty-nine percent indicated that β-blockers are beneficial in the perioperative period. Of those identifying benefit, 8% recognized decrease in myocardial infarction or decrease in mortality as the reason. Sixty-nine percent of patients who identified perioperative benefit cited blood pressure control as the reason. This correlated to the 67% of the total sample who identified their indication for the medication as antihypertensive. Only 7% recalled their prescribing physician ever mentioning the β-blocker in relation to surgery. The same percentage recalled their surgeon mentioning it in relation to the planned procedure. Conclusions: This study suggests low patient understanding of the potential importance and reasons for perioperative β-blockade. Patients who recognized perioperative benefit identified antihypertensive versus cardioprotective effects. Clinicians can improve education of patients already taking daily β-blockers regarding these potential benefits.

AB - Objective: Perioperative β-adrenergic blockade has been shown to decrease morbidity and mortality after noncardiac surgery. The objective of this study was to determine patient knowledge of the importance of perioperative β-blockade in a population already taking chronic therapy and to assess the effectiveness of medical and surgical providers in patient education regarding these benefits. Design: Survey. Setting: Teaching hospital. Participants: One hundred twenty-six patients taking daily β-blockers presenting to a preoperative medical evaluation clinic completed a 12-question survey that assessed their understanding of the potential benefit of taking the medication in the perioperative period. Intervention: None. Measurements and Main Results: Mean coronary artery disease risk factors per individual were 3.2 (standard deviation, 1.5). Forty-nine percent indicated that β-blockers are beneficial in the perioperative period. Of those identifying benefit, 8% recognized decrease in myocardial infarction or decrease in mortality as the reason. Sixty-nine percent of patients who identified perioperative benefit cited blood pressure control as the reason. This correlated to the 67% of the total sample who identified their indication for the medication as antihypertensive. Only 7% recalled their prescribing physician ever mentioning the β-blocker in relation to surgery. The same percentage recalled their surgeon mentioning it in relation to the planned procedure. Conclusions: This study suggests low patient understanding of the potential importance and reasons for perioperative β-blockade. Patients who recognized perioperative benefit identified antihypertensive versus cardioprotective effects. Clinicians can improve education of patients already taking daily β-blockers regarding these potential benefits.

KW - β-blocker

KW - myocardial infarction

KW - patient education

KW - perioperative

UR - http://www.scopus.com/inward/record.url?scp=34249746242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249746242&partnerID=8YFLogxK

U2 - 10.1053/j.jvca.2007.02.001

DO - 10.1053/j.jvca.2007.02.001

M3 - Article

C2 - 17544881

AN - SCOPUS:34249746242

VL - 21

SP - 325

EP - 329

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 3

ER -